Sign in

CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company

Foghorn Therapeutics Inc.

Sign in to watch
Ticker
FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-586-3100
Business address
500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
  1. SC 13D Stake Beneficial Ownership Report
  2. 4 Conversion See Remarks acquired 25,225 shares (conversion)
  3. 4 Open-market buy 10% owner bought 150,000 shares at $16.00 ($2,400,000)
  4. 4 Open-market buy Former 10% Owner bought 150,000 shares at $16.00 ($2,400,000)
  5. 8-K Event Bylaws or fiscal year change
  6. 424B4 Offering Prospectus
  7. 424B4 Offering Prospectus
  8. EFFECT Other Notice of Effectiveness
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 17 of 18 · 356 filings